• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型纤溶酶原激活物受体在肌动蛋白细胞骨架和细胞运动的调节中发挥作用。

The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility.

作者信息

Kjøller Lars

机构信息

The Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.

出版信息

Biol Chem. 2002 Jan;383(1):5-19. doi: 10.1515/BC.2002.002.

DOI:10.1515/BC.2002.002
PMID:11928822
Abstract

Cell migration is a complex process requiring tight control of several mechanisms including dynamic reorganization of the actin cytoskeleton and adhesion to the extracellular matrix. The GPI-anchored urokinase plasminogen activator receptor (uPAR) has an important role in the regulation of cell motility in many cell types. This is partly due to the localization of proteolytic activity on the cell surface by binding of the serine protease uPA. Results accumulated over the last decade suggest that uPAR is also involved in motility control through other mechanisms. These include induction of signal transduction events after ligation with uPA, binding to the extracellular matrix molecule vitronectin (VN), and association with integrins and other transmembrane partners. In this review these mechanisms will be discussed with a special emphasis on how the GPI-linked receptor transmits signals to the intracellular milieu and how uPAR participates in the regulation of actin cytoskeleton reorganization and cell adhesion during cell migration.

摘要

细胞迁移是一个复杂的过程,需要对多种机制进行严格控制,包括肌动蛋白细胞骨架的动态重组以及与细胞外基质的黏附。糖基磷脂酰肌醇(GPI)锚定的尿激酶型纤溶酶原激活物受体(uPAR)在多种细胞类型的细胞运动调节中发挥着重要作用。这部分是由于丝氨酸蛋白酶uPA的结合使蛋白水解活性定位于细胞表面。过去十年积累的研究结果表明,uPAR还通过其他机制参与运动控制。这些机制包括与uPA结合后诱导信号转导事件、与细胞外基质分子玻连蛋白(VN)结合以及与整合素和其他跨膜伴侣相互作用。在这篇综述中,将讨论这些机制,特别强调GPI连接的受体如何将信号传递到细胞内环境,以及uPAR如何在细胞迁移过程中参与肌动蛋白细胞骨架重组和细胞黏附的调节。

相似文献

1
The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility.尿激酶型纤溶酶原激活物受体在肌动蛋白细胞骨架和细胞运动的调节中发挥作用。
Biol Chem. 2002 Jan;383(1):5-19. doi: 10.1515/BC.2002.002.
2
Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.纤溶酶原激活物抑制剂-1和蛋白酶连接蛋白-1对尿激酶受体(CD87)介导的细胞黏附的相互调节作用
J Cell Sci. 2004 Jan 26;117(Pt 3):477-85. doi: 10.1242/jcs.00861. Epub 2003 Dec 16.
3
The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.尿激酶型纤溶酶原激活物(uPA)受体和玻连蛋白的生长调节素B区域将uPA定位于微血管内皮细胞的粘着斑。
Matrix Biol. 2007 Jun;26(5):359-70. doi: 10.1016/j.matbio.2007.01.009. Epub 2007 Feb 6.
4
Aspirin inhibits highly invasive prostate cancer cells.阿司匹林可抑制高侵袭性前列腺癌细胞。
Int J Oncol. 2003 Nov;23(5):1277-83.
5
Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.通过尿激酶连接肽区域与αvβ5整合素之间的新型相互作用激活尿激酶受体。
J Cell Sci. 2006 Aug 15;119(Pt 16):3424-34. doi: 10.1242/jcs.03067. Epub 2006 Aug 1.
6
Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.白细胞介素-1α通过调节α6β1整合素和尿激酶型纤溶酶原激活剂受体的表达增强胰腺癌细胞的侵袭行为。
BMC Cell Biol. 2006 Feb 20;7:8. doi: 10.1186/1471-2121-7-8.
7
The interaction between urokinase receptor and vitronectin in cell adhesion and signalling.尿激酶受体与玻连蛋白在细胞黏附及信号传导中的相互作用
Eur J Cell Biol. 2008 Sep;87(8-9):617-29. doi: 10.1016/j.ejcb.2008.02.003. Epub 2008 Mar 18.
8
Protease crosstalk with integrins: the urokinase receptor paradigm.蛋白酶与整合素的相互作用:尿激酶受体范例
Thromb Haemost. 2001 Jul;86(1):124-9.
9
Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin.Rac介导细胞骨架重排以及由尿激酶型纤溶酶原激活物受体与玻连蛋白结合所诱导的细胞运动性增加。
J Cell Biol. 2001 Mar 19;152(6):1145-57. doi: 10.1083/jcb.152.6.1145.
10
Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system.黑色素瘤细胞在玻连蛋白上的迁移:纤溶酶原激活系统各组分的调控作用
Int J Cancer. 1997 Mar 28;71(1):116-22. doi: 10.1002/(sici)1097-0215(19970328)71:1<116::aid-ijc19>3.0.co;2-g.

引用本文的文献

1
The uPA/uPAR system in astrocytic wound healing.星形胶质细胞伤口愈合中的尿激酶型纤溶酶原激活物/尿激酶型纤溶酶原激活物受体系统
Neural Regen Res. 2022 Nov;17(11):2404-2406. doi: 10.4103/1673-5374.338991.
2
PAI-1, the Plasminogen System, and Skeletal Muscle.纤溶酶原激活物抑制物-1、纤溶酶原系统与骨骼肌
Int J Mol Sci. 2020 Sep 25;21(19):7066. doi: 10.3390/ijms21197066.
3
HGF Modulates Actin Cytoskeleton Remodeling and Contraction in Testicular Myoid Cells.肝细胞生长因子调节睾丸肌样细胞中的肌动蛋白细胞骨架重塑和收缩。
Biomedicines. 2015 Jan 28;3(1):89-109. doi: 10.3390/biomedicines3010089.
4
Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.转基因乳腺癌的自发性肺和淋巴结转移与尿激酶受体uPAR无关。
Clin Exp Metastasis. 2015 Aug;32(6):543-54. doi: 10.1007/s10585-015-9726-1. Epub 2015 Jun 4.
5
Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.止血和静脉功能不全中的临时基质沉积:非愈合性静脉溃疡的组织预处理
Adv Wound Care (New Rochelle). 2015 Mar 1;4(3):174-191. doi: 10.1089/wound.2013.0462.
6
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.尿激酶型纤溶酶原激活物受体(uPAR)控制癌细胞在间充质和阿米巴样迁移方式中的运动可塑性。
Oncotarget. 2014 Mar 30;5(6):1538-53. doi: 10.18632/oncotarget.1754.
7
Urokinase receptor orchestrates the plasminogen system in airway epithelial cell function.尿激酶受体在气道上皮细胞功能中的纤溶酶原系统中起协调作用。
Lung. 2013 Apr;191(2):215-25. doi: 10.1007/s00408-013-9450-z. Epub 2013 Feb 14.
8
Prostate cancer cell surface-associated keratin 8 and its implications for enhanced plasmin activity.前列腺癌细胞表面相关角蛋白 8 及其对增强纤溶酶活性的影响。
Protein J. 2012 Mar;31(3):195-205. doi: 10.1007/s10930-011-9388-z.
9
Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.纤溶酶原激活物抑制剂通过一种依赖尿激酶型纤溶酶原激活物受体(uPAR)的机制调节细胞黏附。
J Cell Physiol. 2009 Sep;220(3):655-63. doi: 10.1002/jcp.21806.
10
The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells.尿激酶型纤溶酶原激活物受体促进凋亡细胞的胞葬作用。
J Biol Chem. 2009 Jun 19;284(25):17030-17038. doi: 10.1074/jbc.M109.010066. Epub 2009 Apr 21.